Eleven Biotherapeutics CEO Steven Kelly receives $3.5M in 2023
Eleven Biotherapeutics reports 2023 executive compensation
By ExecPay News
Published: April 29, 2024
Eleven Biotherapeutics reported fiscal year 2023 executive compensation information on April 29, 2024.
In 2023, six executives at Eleven Biotherapeutics received on average a compensation package of $2.1M, a 108% increase compared to previous year.
Average pay of disclosed executives at Eleven Biotherapeutics
Steven Kelly, Chief Executive Officer, received $3.5M in total. 78% of Kelly's compensation, or $2.7M, was in option awards. Kelly also received $302K in bonus, $461K in salary, as well as $24K in other compensation.
Thomas R. Cannell, Chief Executive Officer, received a compensation package of $3.1M, which increased by 125% compared to previous year. 97% of the compensation package, or $3M, was in other compensation.
Richard Morris, Chief Financial Officer, earned $1.7M in 2023.
Michael Klichinsky, Chief Scientific Officer, received $1.6M in 2023.
Monica Forbes, Chief Financial Officer, earned $1.3M in 2023, a 52% increase compared to previous year.
Mark Sullivan, General Counsel, received $1.1M in 2023, which increases by 63% compared to 2022.
Related executives
Steven Kelly
Eleven Biotherapeutics
Chief Executive Officer
Richard Morris
Eleven Biotherapeutics
Chief Financial Officer
Michael Klichinsky
Eleven Biotherapeutics
Chief Scientific Officer
Thomas Cannell
Eleven Biotherapeutics
Chief Executive Officer
Monica Forbes
Eleven Biotherapeutics
Chief Financial Officer
Mark Sullivan
Eleven Biotherapeutics
General Counsel
You may also like
Source: SEC filing on April 29, 2024.